Skip to main content
. Author manuscript; available in PMC: 2021 May 4.
Published in final edited form as: Lancet. 2020 Aug 8;396(10248):402–411. doi: 10.1016/S0140-6736(20)31316-7

Figure: Cumulative incidence of death among adult patients with multidrug-resistant tuberculosis stratified by HIV status and antiretroviral therapy use.

Figure:

Only includes patients with a known outcome date: 5584 (69%) 8037 of HIV-negative individuals, 2445 (82%) of 2997 HIV-positive individuals on ART, and 403 (45%) of 886 HIV-positive individuals not on ART. The analysis was done in a competing risks framework with death as the outcome and failure as the competing risk. Treatment success was used as the censoring event. Patients who were lost to follow-up were excluded from this analysis. ART=antiretroviral therapy.